New concepts in the pathophysiology of heart failure: Beneficial and deleterious interaction of endogenous haemodynamic and neurohormonal mechanisms

Journal of Internal Medicine

Volumn 239, Issue 4, 1996, Pages 327-333

  Packer, M ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

Heart failure; Neurohormonal activation; Wall stress

Indexed keywords

DIURETIC AGENT; NEUROHORMONE; VASODILATOR AGENT;

CONFERENCE PAPER; DISEASE COURSE; EDEMA; FLUID RETENTION; HEART FAILURE; HEART STRESS; HEMODYNAMICS; HUMAN; MODEL; MYOCARDIAL DISEASE; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYMPTOM;

EID: 0029984396     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.1996.463796000.x     Document Type: Conference Paper

References (28)

1. Packer M. How should physicians view heart failure? The philosophical and physiological evolution of three conceptual models of the disease. Am J Cardiol 1993; 71: 3C-11C.
2. Packer M. Pathophysiology of chronic heart failure. Lancet 1992; 340: 88-92.
3. Packer M. Neurohormonal interactions and adaptations in congestive heart failure. Circulation 1988; 77: 721-7.
4. Packer M. The neurohormonal hypothesis: a theory to explain the mechanism of disease progression in heart failure. J Am Coll Cardiol 1992; 20: 248-54.
5. Kentish JC, ter Kairs KEDJ, Ricciardi L, Bucx JJJ, Noble MIM. Comparison between the sarcomere length-force relations of intact and skinned trabeculae from rat right ventricle. Circ Res 1986; 58: 755-68.
6. Hirsch AT, Dzau VJ, Creager MA. Baroreceptor function in congestive heart failure: effect on neurohormonal activation and regional vascular resistance. Circulation 1987; 75 (Suppl. IV): 36-18.
7. Floras JS. Sympathoinhibitory effects of atrial natriuretic factor in normal humans. Circulation 1990; 81: 1860-73.
8. Capasso JM, Palakai T, Anversa P. Ventricular remodelling induced severe myocardial dysfunction in the aging rat heart. Am J Physiol 1990; 259: H1086-96.
9. Moe GW, Grima EA, Angus C et al. Response of atrial natriuretic factor to acute and chronic increases of atrial pressure in experimental heart failure in dogs: role of changes in heart rate, atrial dimensions, and cardiac tissue concentrations. Circulation 1991; 85: 1780-7.
10. Bristow MR, Hershberger RE, Port JD, et al. β-adrenergic pathways in nonfailing and failing human ventricular myocardium. Circulation 1990; 82 (Suppl. I): 12-25.
11. Forster C, Armstrong PW. Pacing-induced heart failure in the dog: evaluation of peripheral vascular α-adrenoceptor subtypes. J Cardiovasc Pharmacol 1990; 16: 708-18.
12. Creager MA, Faxon DP, Cutler SS, Kohlman O, Ryan TJ, Gavras H. Contribution of vasopressin to vasoconstriction in patients with congestive heart failure: comparison with the renin-angiotensin system and the sympathetic nervous system. J Am Coll Cardiol 1986; 7: 758-65.
13. Marguiles KB, Hildebrand FL, Lerman A, Perrella MA, Burnett, Jr, JC. Increased endothelin in experimental heart failure. Circulation 1990; 82: 2226-30.
14. Cody RJ, Atlas SA, Laragh JH et al. Atrial natriuretic factor in normal subjects and heart failure patients: plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest 1986; 78: 1362-74.
15. Kubo SH, Rector TS, Bank AJ, Williams RE, Heifetz SM. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 1991; 84: 1589-96.
16. Sinoway L, Minotti J, Musch T et al. Enhanced metabolic vasodilation secondary to diuretic therapy in decompensated congestive heart failure secondary to coronary artery disease. Am J Cardiol 1987; 60: 107-11.
17. Creager MA, Quigg RJ, Ren CJ, Roddy M-A, Colucci WS. Limb vascular responsiveness to β-adrenergic receptor stimulation in patients with congestive heart failure. Circulation 1991; 83: 1873-9.
18. Eisjaer H, Bagger JP, Danielsen H et al. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system. Am J Physiol 1991; 260: F883-9.
19. DiBona GF, Sawin LL. Role of renal nerves in sodium retention of cirrhosis and congestive heart failure. Am J Physiol 1991; 260: R298-305.
20. Abassi Z, Haramati A, Hoffman A, Burnett, Jr, JC, Winaver J. Effect of converting-enzyme inhibition on renal response to ANF in rats with experimental heart failure. Am J Physiol 1990; 259: R84-9.
21. Packer M. Interaction of prostaglandins and angiotensin II in the modulation of renal function in congestive heart failure. Circulation 1988; 77 (Suppl. I): 64-73.
22. Connelly CM, McLaughlin RJ, Vogel WM, Apstein CS. Reversible and irreversible elongation of ischemic, infarcted, and healed myocardium in response to increases in preload and afterload. Circulation 1991; 84: 387-99.
23. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation 1992; 85: 790-804.
24. Tan LB, Jalil JE, Pick R, Janicki JS, Weber KT. Cardiac myocyte necrosis induced by angiotensin II. Circ Res 1991; 69: 1185-95.
25. Belch JJF, Budges AB, Scott N, Chopra M. Oxygen free radicals and congestive heart failure. Br Heart J 1991; 65: 245-8.
26. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in congestive heart failure. N Engl J Med 1990; 323: 236-41.
27. Gulick T, Chung MK, Pieper SJ, Lange JG, Schreiner GF. Interleukin-1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA 1989; 86: 6753-7.
28. Lefer M, Aoki N. Leukocyte-dependent and leukocyte-independent mechanisms of impairment of endothelium-mediated vasodilatation. Blood Vessels 1990; 27: 162-8.